HomeCompareTBIIF vs CHD

TBIIF vs CHD: Dividend Comparison 2026

TBIIF yields 1036.27% · CHD yields 1.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBIIF wins by $25725839.72M in total portfolio value
10 years
TBIIF
TBIIF
● Live price
1036.27%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25725839.75M
Annual income
$21,621,439,583,760.49
Full TBIIF calculator →
CHD
CHD
● Live price
1.28%
Share price
$93.32
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,302.64
Full CHD calculator →

Portfolio growth — TBIIF vs CHD

📍 TBIIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBIIFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBIIF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBIIF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBIIF
Annual income on $10K today (after 15% tax)
$88,082.90/yr
After 10yr DRIP, annual income (after tax)
$18,378,223,646,196.41/yr
CHD
Annual income on $10K today (after 15% tax)
$108.62/yr
After 10yr DRIP, annual income (after tax)
$1,107.24/yr
At 15% tax rate, TBIIF beats the other by $18,378,223,645,089.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBIIF + CHD for your $10,000?

TBIIF: 50%CHD: 50%
100% CHD50/50100% TBIIF
Portfolio after 10yr
$12862919.89M
Annual income
$10,810,719,792,531.56/yr
Blended yield
84.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

TBIIF
No analyst data
Altman Z
-1.4
Piotroski
4/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+5.4% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBIIF buys
0
CHD buys
0
No recent congressional trades found for TBIIF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBIIFCHD
Forward yield1036.27%1.28%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$25725839.75M$26.4K
Annual income after 10y$21,621,439,583,760.49$1,302.64
Total dividends collected$25413775.30M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TBIIF vs CHD ($10,000, DRIP)

YearTBIIF PortfolioTBIIF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$114,327$103,626.94$10,857$157.30+$103.5KTBIIF
2$1,229,559$1,107,229.12$11,814$196.49+$1.22MTBIIF
3$12,444,586$11,128,957.58$12,887$245.97+$12.43MTBIIF
4$118,585,021$105,269,314.53$14,097$308.68+$118.57MTBIIF
5$1,064,377,630$937,491,656.85$15,473$388.49+$1064.36MTBIIF
6$9,002,993,282$7,864,109,218.63$17,046$490.55+$9002.98MTBIIF
7$71,799,778,612$62,166,575,799.71$18,861$621.76+$71799.76MTBIIF
8$540,175,955,838$463,350,192,723.20$20,973$791.47+$540175.93MTBIIF
9$3,835,888,007,095$3,257,899,734,348.78$23,454$1,012.51+$3835887.98MTBIIF
10$25,725,839,751,352$21,621,439,583,760.49$26,398$1,302.64+$25725839.72MTBIIF

TBIIF vs CHD: Complete Analysis 2026

TBIIFStock

Tobii AB (publ) develops and sells eye-tracking technology and solutions in Sweden, rest of Europe, the United States, Canada, Asia/Oceania, and internationally. It operates in two segments, Products & Solutions, and Integrations. The Products & solutions segments provides a suite of eye tracking hardware, which includes the Tobii Pro Glasses 3; research-grade and screen-based eye trackers, such as Pro Spectrum and Pro Fusion; and the Tobii Eye Tracker 5, a gaming eye tracker. This segment also includes software Tobii Pro Lab, Sticky, and the consultancy service Tobii Pro Insight. The Integration segment offers algorithms, software, hardware components, system reference designs, and IP-licenses to provide tailored solutions to address industry-specific problems. It serves the scientific studies and research, healthcare, assistive devices, education and training, gaming, extended reality, automotive, and other sectors. The company offers its products through resellers, agents, and distributors. Tobii AB (publ) was founded in 2001 and is headquartered in Danderyd, Sweden.

Full TBIIF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this TBIIF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBIIF vs SCHDTBIIF vs JEPITBIIF vs OTBIIF vs KOTBIIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.